Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53
Open Access
- 18 December 2003
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 11 (1), 79-84
- https://doi.org/10.1038/sj.gt.3302146
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Gene Therapy Death Prompts Review of Adenovirus VectorScience, 1999
- Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trialsNature Medicine, 1999
- A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitorsNature Biotechnology, 1999
- Extensive Cross-Reactivity of Adenovirus-Specific Cytotoxic T CellsHuman Gene Therapy, 1998
- Circumvention of Anti-Adenovirus Neutralizing Immunity by Administration of an Adenoviral Vector of an Alternate SerotypeHuman Gene Therapy, 1997
- “Sero-Switch” Adenovirus-MediatedIn VivoGene Transfer: Circumvention of Anti-Adenovirus Humoral Immune Defenses Against Repeat Adenovirus Vector Administration by Changing the Adenovirus SerotypeHuman Gene Therapy, 1996
- Characterization of Human Proliferative T Cell Responses to AdenovirusThe Journal of Infectious Diseases, 1995
- WORLDWIDE EPIDEMIOLOGY OF HUMAN ADENOVIRUS INFECTIONSAmerican Journal of Epidemiology, 1983
- EPIDEMIOLOGY OF GROUP II ADENOVIRUSES1American Journal of Epidemiology, 1967
- Adenoidal-Pharyngeal-Conjunctival AgentsNew England Journal of Medicine, 1954